Novel Agents Versus Conventional Drugs for the Treatment of Relapsed Multiple Myeloma Patients: Experience of a Single Center over the Last 25 Years

被引：0
|
作者：
Grammatico, Sara [1 ]
Lisi, Elisabetta [1 ]
Cesini, Laura [1 ]
Vallone, Maria Letizia [1 ]
Capria, Saveria [1 ]
Foa, Robin [1 ]
Petrucci, Maria Teresa [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CARFILZOMIB TREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: SINGLE CENTER EXPERIENCE
    Uysal, A.
    Ozkan, M. Comert
    Soyer, N. Akad
    Sahin, F.
    Vural, F.
    Tobu, M.
    Tombuloglu, M.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S29 - S30
  • [2] Daratumumab for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Center Experience
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Neri, Paola
    Luider, Joanne
    Tay, Jason
    Bahlis, Nizar J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E67 - E68
  • [3] Bortezomib in relapsed and refractory multiple myeloma patients.: Experience of a single center
    Calabrese, E.
    Gallucci, C.
    Federico, V
    Mohamad, A.
    Foa, R.
    Petrucci, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151
  • [4] VDCR as a treatment option for refractory or relapsed multiple myeloma in Bortezomib pretreated patients, a single center experience
    Dobrosch, L.
    Hahn-Ast, C.
    Mayer, K.
    von Lilienfeld-Toal, M.
    Brossart, P.
    Janzen, V
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 162 - 162
  • [5] IMPACT OF NOVEL AGENTS ON AGGRESSIVE RELAPSE OF MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE
    Martino, E.
    Parisi, M.
    Calafiore, V
    Sapienza, G.
    Del Fabro, V
    Romano, A.
    Conticello, C.
    Di Raimondo, F.
    HAEMATOLOGICA, 2018, 103 : 38 - 39
  • [6] Bortezomib and dexamethasone for Japanese patients with relapsed and refractory multiple myeloma: a single center experience
    Igarashi, Natsue
    Chou, Takaaki
    Hirose, Takayuki
    Imai, Yousuke
    Ishiguro, Takuro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (03) : 518 - 523
  • [7] Bortezomib and dexamethasone for Japanese patients with relapsed and refractory multiple myeloma: a single center experience
    Natsue Igarashi
    Takaaki Chou
    Takayuki Hirose
    Yousuke Imai
    Takuro Ishiguro
    International Journal of Hematology, 2010, 92 : 518 - 523
  • [8] Aya-Myeloma: Real World, Single Center Experience Over Last 5 Years
    Yanamandra, Uday
    Saini, Neha
    Khadwal, Alka
    Prakash, Gaurav
    Lad, Deeepesh
    Varma, Neelam
    Varma, Subhash
    Malhotra, Pankaj
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E54 - E54
  • [9] Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience
    Uysal, Ayse
    Akad Soyer, Nur
    Ozkan, Melda
    Sahin, Fahri
    Vural, Filiz
    Tobu, Mahmut
    Tombuloglu, Murat
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 80 - 83
  • [10] Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years
    Steiner, Normann
    Schober, Paula
    Willenbacher, Wolfgang
    Kircher, Brigitte
    Gunsilius, Eberhard
    Wolf, Dominik
    Nachbaur, David
    ANTICANCER RESEARCH, 2022, 42 (12) : 5825 - 5832
12345